Aehr Test Systems is expected to report fiscal Q1 2027 revenue of $27.04 million and non-GAAP EPS of $0.11, with its current share price of $101.60 trading below the average analyst target of $128.00.
The primary focus for investors is the company’s ability to convert its record $100.6 million effective backlog into realized revenue as it pivots from electric vehicle silicon carbide testing to artificial intelligence and silicon photonics.
This strategic shift follows a period of consolidation, with management guiding for fiscal 2027 revenue growth of 160% to 200% driven by hyperscale AI demand. Analysts will be scrutinizing the Q1 2027 shipment cadence and new order intake to confirm that these high-growth targets remain achievable.